Acetazolamide


Curated chemical-gene interactions from CTD
Entrez gene IDGene symbolInteraction typeReference
10142 AKAP9 Increases expression PMID:19274763
10397 NDRG1 Increases expression PMID:19274763
10509 SEMA4B Increases expression PMID:19274763
10586 MAB21L2 Decreases expression PMID:19274763
11238 CA5B Decreases activity PMID:28251759
11335 CBX3 Increases expression PMID:19274763
1153 CIRBP Increases expression PMID:19274763
1182 CLCN3 Increases expression PMID:19274763
161291 TMEM30B Increases expression PMID:19274763
1654 DDX3X Increases expression PMID:19274763
1656 DDX6 Increases expression PMID:19274763
170938 ZFP617 Increases expression PMID:19274763
17748 MT1 Decreases expression PMID:19274763
1824 DSC2 Increases expression PMID:19274763
19 ABCA1 Increases expression PMID:19274763
196528 ARID2 Increases expression PMID:19274763
218100 ZFP322A Increases expression PMID:19274763
23451 SF3B1 Increases expression PMID:19274763
23476 BRD4 Increases expression PMID:19274763
23526 ARHGAP45 Affects expression PMID:25811541
23632 CA14 Decreases activity PMID:28251759
27316 RBMX Increases expression PMID:19274763
2734 GLG1 Increases expression PMID:19274763
2752 GLUL Increases expression PMID:19274763
29970 SCHIP1 Increases expression PMID:19274763
338351 AKAP17B Increases expression PMID:19274763
3480 IGF1R Increases expression PMID:19274763
358 AQP1 Decreases expression PMID:17219999
3709 ITPR2 Increases expression PMID:19274763
377677 CA13 Decreases activity PMID:28251759
4214 MAP3K1 Increases expression PMID:19274763
5178 PEG3 Increases expression PMID:19274763
5451 POU2F1 Increases expression PMID:19274763
5495 PPM1B Increases expression PMID:19274763
5530 PPP3CA Increases expression PMID:19274763
5654 HTRA1 Increases expression PMID:19274763
57713 SFMBT2 Increases expression PMID:19274763
6304 SATB1 Increases expression PMID:19274763
6309 SC5D Increases expression PMID:19274763
6385 SDC4 Increases expression PMID:19274763
6474 SHOX2 Increases expression PMID:19274763
65125 WNK1 Increases expression PMID:19274763
6599 SMARCC1 Increases expression PMID:19274763
6809 STX3 Increases expression PMID:19274763
6815 STYX Increases expression PMID:19274763
7072 TIA1 Increases expression PMID:19274763
7369 UMOD Increases expression PMID:2655449
759 CA1 Decreases activity PMID:11430635; PMID:19231207; PMID:28117934; PMID:29131470; PMID:29283199; PMID:29457667; PMID:29975450; PMID:29992664; PMID:30291660; PMID:30368973; PMID:30431690; PMID:30537031; PMID:31581370; PMID:17826101; PMID:28251759
760 CA2 Decreases activity PMID:11430635; PMID:16858005; PMID:19231207; PMID:21851094; PMID:28117934; PMID:29131470; PMID:29283199; PMID:29457667; PMID:29975450; PMID:29992664; PMID:30291660; PMID:30368973; PMID:30431690; PMID:30537031; PMID:31581370; PMID:17826101; PMID:28251759
761 CA3 Decreases activity PMID:17826101
762 CA4 Decreases activity PMID:28251759
763 CA5A Decreases activity PMID:28251759
765 CA6 Decreases activity PMID:28251759
766 CA7 Decreases activity PMID:28251759
768 CA9 Decreases activity PMID:21851094; PMID:28251759
7706 TRIM25 Increases expression PMID:19274763
771 CA12 Decreases activity PMID:21851094; PMID:28251759
80155 NAA15 Increases expression PMID:19274763
8125 ANP32A Increases expression PMID:19274763
8204 NRIP1 Increases expression PMID:19274763
83607 AMMECR1L Increases expression PMID:19274763
894 CCND2 Increases expression PMID:19274763
9584 RBM39 Increases expression PMID:19274763
961 CD47 Increases expression PMID:19274763

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.